AzTrials
AzTrials

Depressive SymptomsNCT04889508

Investigating Differential Effects of Online Mental Training Interventions on Mental Well-being and Social Cohesion

A study testing Socio-emotional mental training and Mindfulness-based mental training in people with Depressive Symptoms and Stress, run by Max Planck Social Neuroscience Lab at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The SARS-CoV-2 pandemic, and the associated government-imposed isolationary lockdowns, has led to a mental health crisis on a global scale. Empirical studies have reported a drastic increase in mental health problems, such as depression and anxiety, increased loneliness and feelings of disconnectedness from others… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Depressive Symptoms, Stress, Empathy
What is being tested?
Socio-emotional mental training and Mindfulness-based mental training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
285 participants
Where
1 siteGermany
Study dates
7 May 2021to 31 Mar 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Participants will have to meet the following inclusion criteria:
  • between 18 and 65 years age
  • resident of Berlin
  • proficiency in German.

Who cannot join

  • Participants would be excluded:
  • if they do not have access to internet or technical equipment necessary
  • if they have an educational background in psychology
  • if they have regular spiritual practice (including yoga practice with meditative component)
  • if they take medication that influences physiological markers
  • if they have participated in stress reduction programs previously
Show all 11Show fewer
  • if they suffer from a chronic illness or pain, or if they have a history of or current psychiatric diagnosis.
  • Toronto Alexithymia Scale-20 (TAS-20; exclude if score greater than 60)
  • Patient Health Questionnaire-9 (PHQ-9; exclude if scores greater than 19)
  • Generalized Anxiety Disorder-7 (GAD-7; exclude if scores greater than 15)
  • Moreover, participants endorsing suicidality on the PHQ-9 will be excluded. Lastly, participants will be further screened for personality disorder on the Standardized Assessment of Severity of Personality Disorder questionnaire and for endorsement of clinical levels of psychological disorder on CID-S.

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Social Neuroscience Lab

    Berlin

Other trials in Germany

About this study

Official title: Investigating the Differential Effects of Online Mental Training Interventions on Mental Well-being and Social Cohesion

The SARS-CoV-2 pandemic, and the associated government-imposed isolationary lockdowns, has led to a mental health crisis on a global scale. Empirical studies have reported a drastic increase in mental health problems, such as depression and anxiety, increased loneliness and feelings of disconnectedness from others, while resilience levels have been negatively affected, indicating an urgent need for intervention. The current study study is embedded in a larger study, the CovSocial study (www.covsocial) which focused in its first phase on evaluating the longitudinal changes in vulnerability, resilience and social cohesion during the SARS-CoV-2 pandemic. The present second phase of this CovSocial study will seek to investigate the efficacy of brief online mindfulness-based and socio-emotional interventions in reducing mental health problems, and enhancing psychological resilience, social competencies and social cohesion.

After providing informed consent, participants will be assigned to one of three groups: 1) socio-emotional training group (with Affect Dyads as core exercise), 2) mindfulness-based mental training group (with attention-based mindfulness practices such as Breathing Meditation as core practice), or 3) Retest Control Group (waitlist control).All groups will first undergo a pre-intervention testing phase (pre-test) wherein they will provide a comprehensive baseline measurement which covers psychometric measures (such as questionnaires and behavioral tasks), and biological parameters (saliva samples). During the 10-week intervention period, participants will undergo weekly assessments and daily Ecological Momentary Assessment pre and post the daily exercise practice, using self-report scales and questionnaires delivered through a webapp or mobile app. At the end of the intervention, participants will again undergo an assessment of psychometric measures and biological parameters, same as at pre-intervention time (post-test). In a second portion, the waitlist control group will undergo the socio-emotional intervention and will be tested at post-test II again.

Read more

Results will reveal the effectiveness of brief online interventions in enhancing mental health and social cohesion outcomes. In addition to examining pre-post intervention-related changes, we will also use the data from the phase 1 of the project to evaluate the impact of trait markers of and the longitudinal changes in vulnerability, resilience and social cohesion on the intervention-related changes in markers of vulnerability, resilience and social cohesion. We will also evaluate the predictive impact of genetic markers of vulnerability, resilience and social cohesion (assessed in phase 1) on intervention-related changes in our variables of interest.

The present study will serve as a pilot for future application of scalable, low-cost interventions at a broader level to reduce stress, improve mental health and build resilience in the face of global stressors.

Being tested
Socio-emotional mental training, Mindfulness-based mental training
Medical subject headings
Depression, Altruism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Socio-emotional mental trainingBehavioural

    Core practice: Affect Dyad. In the Affect Dyad (AD), participants perform a 12-minute partner-based exercise which involves contemplating over one difficult situation and one situation which incurred gratitude in the past 24 hours. Both partners take turns speaking about the two situations while the other partner listens in a non-judgmental manner. While the participants elaborate on the situations, they are asked to focus on the bodily experience of the emotions generated during the situation. The goal of the exercise is to enhance coping with difficult emotions, empathic listening, social sharing, acceptance, and gratitude.

  • Mindfulness-based mental trainingBehavioural

    Core practice: Breathing Meditation. In this intervention, participants will practice 12-minute basic attention-based mindfulness meditation such as the Breathing Meditation (BM). BM is a 12-minute individual exercise that requires participants to focus their attention on the sensations of breathing. Participants have to sustain their attention to breath for long stretches of time, and have to return their attention to their breath when their mind wanders. The key focus is on training attention and interoceptive body awareness. Other practices participants will be taught is mindfulness on sounds (here the object of attention is not the breath but sounds in the environment).

Study groups in NCT04889508
Study groupRoleWhat they receive
Socio-emotional mental trainingExperimentalThe socio-emotional intervention will consist of 10 weeks of daily Affect Dyad practice with a partner.
Receives: Behavioral: Socio-emotional mental training
Mindfulness-based mental trainingExperimentalThe intervention will consist of 10 weeks of daily individual Breathing Meditation practice.
Receives: Behavioral: Mindfulness-based mental training
Retest Control Group (Waitlist control)OtherThe retest control group, which is also a waitlist control group, will first not undergo an intervention, but will be tested prior to and after the 10-week period at Pre- and Post-test wherein other groups undergo the interventions. In a second step, the waitlist control group will then also undergo a 10-week period of socio-emotional intervention. During the first 10-week intervention period, this group will only be tested serving as a re-test control group. After Post-test, however, they will be given the chance to also enroll in a 10-week socio-emotional mental training with the exact same protocol as the socio-emotional intervention experimental group above. Both the experimental intervention arm groups will be given the possibility to continue their daily assigned practices (respective socio-emotional and mindfulness-based training exercises) after post-test for the duration of the 10-weeks during which the waitlist control group undergoes the socio-emotional intervention.
Receives: Behavioral: Socio-emotional mental training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline Beck Depression Inventory (BDI)-II scores at 10 weeks

    A scale measuring depression symptoms. Higher scores indicate more depression symptoms.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  2. Change from baseline State Trait Anxiety Inventory (STAI) scores at 10 weeks

    A scale measuring state and trait anxiety symptoms. Higher scores indicate more anxiety symptoms.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  3. Change from baseline Connor Davidson Resilience Scale (CDRISC) score at 10 weeks

    A scale measuring psychological resilience. Higher scores indicate more resilience.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  4. Change from baseline UCLA Loneliness Scale at 10 weeks

    A scale measuring loneliness. Higher scores indicate more subjective loneliness.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  5. Change from baseline State Self Compassion Scale (S-SCS) scores at 10 weeks

    A scale measuring compassion towards self. Higher scores indicate more self-compassion.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  6. Change from baseline Perceived Stress Scale (PSS)-10 scores at 10 weeks

    A scale measuring perceived stress. Higher scores indicate more perceived stress.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  7. Change from baseline Interpersonal Reactivity Index (IRI) scores at 10 weeks

    A scale measuring four aspects of empathy. Higher scores indicate more empathy.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  8. Change from baseline Cortisol Awakening Response at 10 weeks

    Cortisol Awakening response.

    Measured: Assessed at pre-intervention over a period 2 days (Baseline), and then after 10-week intervention period at post-intervention timepoint again for 4 days

  9. Change from baseline Subjective Stress levels at 10 weeks

    Assessment of quality of sleep, stressor appraisal, coping with stressor, affective state, valence and temporal orientation of thoughts, perceived emotional control, and interoceptive awareness. Using Ecological Momentary Assessment(EMA).

    Measured: Assessed at pre-intervention over a period 8 days (Baseline), and then after 10-week intervention period at post-intervention timepoint again for 8 days

  10. Change from baseline Brief Resilience Scale (BRS) scores at 10 weeks

    A scale measuring adaptive resilience. Higher scores indicate more resilience.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  11. Change from baseline Difficulties in Emotion Regulation Scale (DERS)-18 scores at 10 weeks

    A scale measuring difficulties in use of emotion regulation strategies. Higher scores indicate more difficulties in emotion regulation.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  12. Change from baseline Cognitive Emotion Regulation Questionnaire (CERQ)-18 scores at 10 weeks

    A scale measuring use of emotion regulation strategies. Higher scores on a strategy sub scale indicate more use of the emotion regulation strategy.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  13. Change from baseline Fear of Compassion Scale (FoC) scores at 10 weeks

    A scale measuring fear of compassion towards self. Higher scores indicate more fear of compassion.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  14. Change from baseline Social Value Orientations (SVO) scores at 10 weeks

    A task measuring social value orientations and prosocial behavior. Number of choices will be used as the dependent variable.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  15. Change from baseline Zurich Prosocial Game scores at 10 weeks

    A behavioral task assessing levels of prosocial behavior towards others. Number of keys invested in will serve as the dependent variable.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  16. Change from baseline EmpaToM scores at 10 weeks

    A behavioral task assessing empathy and theory of mind. Valence and compassion ratings will serve as the dependent variables.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  17. Change from baseline Social Discounting Task scores at 10 weeks

    A behavioral task assessing prosocial behavior and altruism. The degree of discounting will serve as the dependent variable.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  18. Change from baseline Multidimensional Assessment of Interoceptive Awareness (MAIA) scores at 10 weeks

    A scale measuring interoception. Higher scores indicate more interoceptive awareness.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  19. Change from baseline Sussex-Oxford Compassion Scale (SOC) scores at 10 weeks

    A scale measuring compassion. Higher scores indicate more compassion.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  20. Change from baseline Toronto Alexithymia Scale scores at 10 weeks

    A scale measuring Alexithymia. Higher scores indicate more alexithymia.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  21. Change from baseline Trier Social Stress Test (TSST) scores at 10 weeks

    A task assessing cortisol response to social stress. Subjective stress and cortisol levels will serve as the dependent variables.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

Secondary outcomes (38)
  1. Change in baseline Dot Probe Task (mediating variable) scores at 10 weeks

    A behavioral task assessing attention bias toward positive and negative stimuli. Negative and positive attention bias indices will serve as dependent variables.

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  2. Change in baseline Scrambled Sentences Task (mediating variable) scores at 10 weeks

    A behavioral task assessing interpretation bias toward positive and negative stimuli. Negative and positive interpretation bias indices will serve as dependent variables

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  3. CERQ - Acceptance, Rumination, and Reappraisal (explanatory mechanism)

    A scale measuring use of only three emotion regulation strategies

    Measured: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  4. FoC - Fear of Expressing Compassion for Others (explanatory mechanism)

    A scale measuring how much people fear expressing compassion towards others

    Measured: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  5. FoC - Fear of Expressing Kindness and Compassion Towards Oneself (explanatory mechanism)

    A scale measuring how much people fear expressing compassion towards self

    Measured: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  6. S-SCS - Self-kindness (explanatory mechanism)

    A scale measuring levels of kindness shown towards self

    Measured: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  7. S-SCS - Common Humanity (explanatory mechanism)

    A scale measuring feelings of shared humanity

    Measured: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  8. Five Facet Mindfulness Questionnaire (FFMQ; explanatory mechanism)

    A scale measuring mindfulness on 5 different sub scales. 1 item with the highest factor loading on each of the 5 subscales.

    Measured: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  9. Stress Assessment Questions

    A scale assessing the occurrence and nature of a stressor

    Measured: Assessed weekly during the course of 10 weeks of intervention only in intervention groups in the context of a stressor

  10. Inclusion of Other in the Self Scale

    A scale assessing sense of belonging and social connectedness

    Measured: Assessed weekly during the course of 10 weeks of intervention only in intervention groups in the context of a stressor

  11. Frequency and quality of social interaction, and empathic listening

    A scale assessing quality of social interactions and listening

    Measured: Assessed weekly during the course of 10 weeks of intervention only in intervention groups in the context of a stressor

  12. Penn State Worry Questionnaire (PSWQ)-3 (explanatory mechanism)

    A scale measuring levels of worry

    Measured: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  13. IRI - Personal Distress (explanatory mechanism)

    A scale measuring levels of personal distress felt when showing empathic concern

    Measured: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  14. MAIA - Self-Regulation and Body Listening (explanatory mechanisms)

    A scale measuring levels of interoceptive awareness

    Measured: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  15. Cognitive Control and Flexibility Questionnaire (CCFQ) - Cognitive Control over Emotions (explanatory mechanism)

    A scale measuring cognitive control exhibited over emotional material

    Measured: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  16. Acceptance and Action Questionnaire (AAQ)-II (explanatory mechanism)

    A scale measuring psychological flexibility

    Measured: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  17. DERS (explanatory mechanism)

    1 item each from the following subscales: Nonacceptance of emotional responses, Difficulty engaging in Goal-directed behavior, Lack of emotional awareness, Limited access to emotion regulation strategies, Lack of emotional clarity.

    Measured: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  18. Brief-COPE (explanatory mechanism)

    A scale measuring the frequency of 2 coping strategies used - emotional support and instrumental support

    Measured: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  19. PSS-4

    A scale measuring perceived stress

    Measured: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  20. Affect Grid (explanatory mechanism)

    Assessment of emotional state (valence) and arousal

    Measured: Assessed for 10 weeks during intervention period, 3 times a week, only in the intervention groups, prior to and after the daily exercise

  21. Cube of Thoughts (explanatory mechanism)

    A scale measuring the temporality and valence of thoughts

    Measured: Assessed for 10 weeks during intervention period, 3 times a week, only in the intervention groups, prior to and after the daily exercise

  22. Interoception (explanatory mechanism)

    Assessment of how much bodily sensations are felt

    Measured: Assessed for 10 weeks during intervention period, 3 times a week, only in the intervention groups, prior to and after the daily exercise

  23. Engagement (explanatory mechanism)

    Assessment of how engaged participants felt in the exercise

    Measured: Assessed for 10 weeks during intervention period, 3 times a week, only in the intervention groups, only once after the daily exercise

  24. Social connectedness - Inclusion of Other in Self Scale (explanatory mechanism)

    Assessment of how connected participant felt to the dyad partner

    Measured: Assessed for 10 weeks during intervention period, 3 times a week, only in the AD intervention group, prior to and after the daily exercise

  25. Personal Detail Shared (explanatory mechanism)

    Assessment of the level of personal details shared by the participant during exercise

    Measured: Assessed for 10 weeks during intervention period, 3 times a week, only in the AD intervention group, only after the daily exercise

  26. Loneliness (explanatory mechanism)

    Assessment of the level of loneliness by the participant before and after exercise

    Measured: Assessed for 10 weeks during intervention period, 3 times a week, only in the intervention groups, prior to and after the daily exercise

  27. Change from baseline Inflammation Marker levels at 10 weeks

    Assessment of C-reactive protein (CRP) levels through saliva sample

    Measured: Assessed at pre-test (Baseline) and then after 10-week intervention period at post-intervention timepoints

  28. Change from baseline Polyepigenetic risk scores at 10 weeks

    Assessment of epigenetic markers through saliva

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints only in intervention groups

  29. Belonging to COVID-19 biological risk group

    Yes or No

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  30. Belonging to COVID-19 professional risk group

    Yes or No

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  31. Positive test result for COVID-19

    Yes or No

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  32. Presence of COVID-19 symptoms

    Yes or No

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  33. Hospitalization due to COVID-19

    Yes or No

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  34. Duration of hospitalization due to COVID-19 (in weeks)

    Number of weeks

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  35. History of or current presence of long-covid symptoms

    Yes or No

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  36. Status of COVID-19 vaccination

    received none, first or both doses

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  37. Perception of benefits of COVID-19 vaccination

    in case of one or two doses received willingness to receive COVID-19 vaccination (in case of no dose received), and impact of COVID-19 related restrictions and limitations

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  38. Willing to receive COVID-19 vaccination

    Yes or No. Only in case of no dose received

    Measured: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 May 2021
  2. Study start7 May 2021
  3. Primary completion31 Mar 2022
  4. Study completion31 Mar 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
285 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04889508
Sponsor's protocol ID
CovSocialPhase2
Status last verified
Jan 2023
First submitted
6 May 2021
Last updated
23 Jan 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Silveira S, Godara M, Singer T. Boosting Empathy and Compassion Through Mindfulness-Based and Socioemotional Dyadic Practice: Randomized Controlled Trial With App-Delivered Trainings. J Med Internet Res. 2023 Jul 26;25:e45027. doi: 10.2196/45027.

    PubMed 37494106
  • Godara M, Silveira S, Matthaus H, Heim C, Voelkle M, Hecht M, Binder EB, Singer T. Investigating differential effects of socio-emotional and mindfulness-based online interventions on mental health, resilience and social capacities during the COVID-19 pandemic: The study protocol. PLoS One. 2021 Nov 4;16(11):e0256323. doi: 10.1371/journal.pone.0256323. eCollection 2021.

    PubMed 34735441

Questions about this trial

What is this clinical trial studying?

A study testing Socio-emotional mental training and Mindfulness-based mental training in people with Depressive Symptoms and Stress, run by Max Planck Social Neuroscience Lab at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline Beck Depression Inventory (BDI)-II scores at 10 weeks (time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints). The study lists 21 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04889508, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in